Evidence map›Paper›PMID 40485060›Full record

ArticlePharmacology research & perspectives2025

Rapidly Polymerizing Click Hydrogel Provides Localized Delivery of rhBMP2 to Promote Bone Formation.

D Joshua Cohen, Thomas W Jacobs, D Scott Wilson, Michael C Mancini, Christine Van Duyn, Zvi Schwartz, Barbara D Boyan

Abstract read
In one paragraph

Article in Pharmacology research & perspectives, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

D Joshua CohenDepartment of Biomedical Engineering, Virginia Commonwealth University, Richmond, Virginia, USA.
Thomas W JacobsDepartment of Biomedical Engineering, Virginia Commonwealth University, Richmond, Virginia, USA.
D Scott WilsonJohns Hopkins Medical Institute, Baltimore, Maryland, USA.
Michael C ManciniPascal Medical Corporation, Richmond, Virginia, USA.
Christine Van DuynDepartment of Biomedical Engineering, Virginia Commonwealth University, Richmond, Virginia, USA.
Zvi SchwartzDepartment of Biomedical Engineering, Virginia Commonwealth University, Richmond, Virginia, USA.
Barbara D BoyanDepartment of Biomedical Engineering, Virginia Commonwealth University, Richmond, Virginia, USA.ORCID 0000-0002-9642-0311

Funding

Mechanisms Mediating Osseointegration of 3D Printed Titanium ConstructsR01AR072500 · NIAMS · VIRGINIA COMMONWEALTH UNIVERSITY · PI BOYAN, BARBARA D. · 2019 to 2023
$2.9M
Building Interdisciplinary Research Careers in Women's HealthK12AR084233 · NIAMS · VIRGINIA COMMONWEALTH UNIVERSITY · PI Barbara D. Boyan, SUSAN G. KORNSTEIN · 2023 to 2026
$2.2M
Joan and Morgan Massey FoundationNIAMS NIH HHS AR072500NIAMS NIH HHS K12 AR084233NIAMS NIH HHS K12AR084233NIAMS NIH HHS R01 AR072500U.S. Food and Drug Administration RG219-G3VCU VenturesVirginia Biomedical Health Research CorporationVirginia Innovation Partnership Corporation Commonwealth Research Commercialization Fund MF18-008-LS
6 · The paper itself

Abstract

Delivery of bioactive agents to achieve tissue regeneration at targeted sites with minimal side effects requires the use of biodegradable carriers and sustained release of the therapeutic at appropriate concentrations. We developed a copper-free polyethylene glycol-based click hydrogel to deliver bone morphogenetic protein-2 (BMP2), a potent regulator for bone regeneration that is currently delivered to orthotopic sites using an absorbable collagen sponge, leading to a burst release of BMP2, potentially causing ectopic bone formation. In contrast, the hydrogel is delivered as a liquid, conforming to the contours of treatment sites, polymerizing rapidly at body temperature without generating heat, exhibiting minimal swelling after gelation, and releasing its payload as it degrades. We assessed the safety and effectiveness of BMP2 delivery in vitro and in mouse cranial defects in vivo, comparing it to BMP2 delivered via a collagen sponge. No toxicity was observed in vitro or systemically, nor was there allergic sensitization caused by the hydrogel in rabbits. Released BMP2 increased the production of osteogenic markers in vitro. Hydrogel + BMP2 caused equivalent defect closure and total bone growth compared to collagen + BMP2; however, there was more vascularization within the defect but less bone growth outside of the defect on the calvaria for hydrogel + BMP2 compared to collagen + BMP2. In conclusion, the click hydrogels used in this study are safe and effective for administering BMP2 with fewer undesired off-target effects and high potential to be used with BMP2 for bone regeneration, supporting the use of click chemistry hydrogels to deliver bioactive agents to treatment sites safely and effectively.

Indexed as

Bone Morphogenetic Protein 2HydrogelsOsteogenesisAnimalsBone RegenerationClick ChemistryCollagenDrug Delivery SystemsHumansMaleMicePolyethylene GlycolsRabbitsRecombinant ProteinsSkullBone Morphogenetic Protein 2CollagenHydrogelsPolyethylene GlycolsRecombinant ProteinsBMPbonebone morphogenetic protein‐2click chemistryhydrogelin vitroin vivoosteogenesisosteoinduction

Identifiers

PMID40485060
PMCPMC12146212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.